Gagnon Pierre's most recent trade in NKGen Biotech Inc was a trade of 360,000 Stock Option (right to buy done . Disclosure was reported to the exchange on Feb. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NKGen Biotech Inc | Gagnon Pierre | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 360,000 | 360,000 | - | - | Stock Option (right to buy |